A decrease in glucose tolerance, as indicated by a slower rate of disappearance of blood glucose following intravenous glucose administration, has been observed in patients with neoplastic disease (2). The group studied included subjects with chronic diffuse lymphomas and leukemias as well as clinically localized carcinomas who were carefully selected to exclude various other factors known to influence carbohydrate utilization. In view of the fact that the altered glucose metabolism was associated with localized carcinoma, it appeared likely that it reflected a defect in the metabolism of the host. The mechanism of this defect is unknown.
A decrease in glucose tolerance, as indicated by a slower rate of disappearance of blood glucose following intravenous glucose administration, has been observed in patients with neoplastic disease (2) . The group studied included subjects with chronic diffuse lymphomas and leukemias as well as clinically localized carcinomas who were carefully selected to exclude various other factors known to influence carbohydrate utilization. In view of the fact that the altered glucose metabolism was associated with localized carcinoma, it appeared likely that it reflected a defect in the metabolism of the host. The mechanism of this defect is unknown.
In view of suggestions (3, 4) that endogenous insulin secretion determines the rate of blood glucose disappearance, the decreased glucose tolerance might reflect either diminished secretion of, or a diminished responsiveness to, endogenous insulin. On the assumption that sensitivity to exogenously administered insulin reflects responsiveness to the endogenously secreted hormone, insulin response tests have been performed in patients with neoplastic disease. This has been done employing a three hour test procedure which permitted the determination of the rate constant of the decline in blood glucose concentration, first, following the intravenous administration of glucose sufficient to cause hyperglycemia, and second, following the intravenous administration of insulin. It was found that patients with neoplastic disease, compared to control subjects, had an impaired re-*A portion of the present data was presented before the American Association for Cancer Research, April, 1957 , and appears in abstract form (1). sponse to insulin as well as a decreased glucose tolerance.
METHODS
Subjects studied. The control group consisted of 16 individuals without neoplastic disease, eight males and eight females, ranging in age from 36 to 61 years. The patients with neoplastic disease included 24 individuals, 11 males and 13 females, ranging in age from 33 to 71 years. There were no significant differences between the control and the patient groups with respect to age or body weight. The diagnoses of these subj ects are indicated in Tables I and II (5, 6) .
Analysis of the responses to glucose and to insulin administration. The responses to glucose and to insulin administration were analyzed by graphing the logarithm of the total blood glucose concentration against time (7) . It was observed that the blood glucose concentration decreased at an exponential rate during the mid-portion of the period following both glucose and insulin administration. This linear function persisted for at least 40 minutes after glucose administration and at least 12 minutes after insulin administration. It is assumed that during this period of exponential decline of the total blood glucose concentration the slope of the plotted curve provides an index of the response to either glucose or insulin administration. This index may be expressed as the rate constant for the assumed first-order reaction according to the equation: kG or ki = loge 2 ti where kG and k1 are the fractional rate constants of disappearance of blood glucose following glucose or following insulin administration, respectively, and ti/2 is the time in minutes for the total blood glucose concentration to decline 50 per cent from any point after glucose or after insulin administration, respectively. An example of this graphic analysis is presented in Figure 1 .
It has been previously demonstrated (2) that this empirical method of analysis of intravenous glucose tolerance curves provides good reproducibility in a given subject, and good discrimination between the control and neoplastic groups.
RESULTS
The data obtained from the tests of the response to glucose and to insulin administration in 16 control subjects and 24 patients with neoplastic disease are summarized in Tables I and II . The rate constant for the decline in blood glucose concentration after insulin administration (k1) for the control group was 6.90 + 1.86 per cent per minute 2 compared to 3.99 ± 1.30 per cent per minute in the patient group. The similar rate constant after glucose administration (kG) was 1.76 + 0.25 per cent per minute for the control group and 1.18 ± 0.37 per cent per minute for the patient group. The differences between the means of both k, and kG were statistically significant, 5.5 and 5.9 times the standard error of the difference, respectively. The values for kG in the control and patient groups are in agreement with previous studies of a larger number of subjects (2) 
DISCUSSION
A decreased sensitivity to insulin, as indicated by a slower rate of decline in blood glucose concentration following the intravenous administration of this hormone, was observed in patients with neoplastic disease. These subjects also demonstrated impaired glucose tolerance, as previously described (2, (8) (9) (10) (11) (12) (13) .
In terms of the rate of disappearance of blood glucose, the patients with neoplastic disease ex- The left-hand portion of this figure presents the blood glucose concentration data after intravenous administration of glucose followed by insulin in control Subject J.K. The right-hand portion of this figure presents the graphic analysis of these data to obtain the rate constants of glucose disappearance following administration of glucose (kG) and insulin (Ki). T1/2 is the time in minutes for the total blood glucose concentration to decline 50 per cent from any point after glucose or insulin injection.
hibited the same relative degree of unresponsiveness to exogenous insulin as to intravenously administered glucose. This is indicated by the finding that the ratio of the rate constants, kI/kG, did not differ significantly in the patient and control groups. In view of the evidence that the rate of blood glucose disappearance during hyperglycemia may be determined by endogenous insulin secretion (3, 4) , these observations are compatible with the concept that impaired glucose tolerance in patients with neoplastic disease may be a manifestation of a decreased responsiveness to endogenous insulin.
It is to be stressed that a decrease in reponsiveness to insulin is not specific. It has been described in a variety of disorders (14, 15) , including diabetes mellitus, endocrine dysfunctions, hepatic disease and infectious diseases and in association with increasing age (16) .
The present study indicates that decreased in- Hn.
sulin responsiveness is a manifestation of the metabolic alterations associated with neoplasia in the human host, but provides no data which permit conclusions as to the mechanism of this alteration in hormonal control. SUMMARY 1. A procedure for testing the response to intravenous glucose administration as well as the response to intravenous insulin administration has been employed which permits their comparison by means of the rate constant of the decline in blood glucose concentration. This procedure is performed in a given subject during a single three hour study.
2. An impaired response to insulin administration as well as the previously described impairment in glucose tolerance was observed in 24 patients with neoplastic disease, when compared with 16 control subjects.
